Skip to Content

Rimrock Gold Corp RMRK

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RMRK is trading at a 512% premium.
Price
$0.00
Fair Value
$8.47
Uncertainty
Extreme
1-Star Price
$3.37
5-Star Price
$6.62
Economic Moat
Nvt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMRK is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$1.15 Mil
Volume/Avg
800,025 / 11.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Rimrock Gold Corp is engaged in research, development, and sales of unique CBD products such as CBD oils and hemp extracts on a large scale. the company acquired Hemp Tradition, LLC through its wholly owned subsidiary Acqua Cannabis. and also looking forward to more acquisitions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
2

Valuation

Metric
RMRK
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
RMRK
Quick Ratio
0.01
Current Ratio
0.01
Interest Coverage
−2.22
Quick Ratio
RMRK

Profitability

Metric
RMRK
Return on Assets (Normalized)
−182.34%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−217.67%
Return on Assets
RMRK
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AVxjkynbysRvjwl$79.4 Bil
MKKGY
Merck KGaA ADRGwyrllbfkVgrqym$79.0 Bil
HLN
Haleon PLC ADRVpfwxfpNmr$38.5 Bil
VTRS
Viatris IncNbpkvmcRkxgb$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRDtnpdzkjcHvvlg$11.7 Bil
CTLT
Catalent IncYpghybptSpqsbw$10.0 Bil
CURLF
Curaleaf Holdings IncDtfcpbfMvh$4.2 Bil
PRGO
Perrigo Co PLCMnvsyjkzJglct$4.1 Bil
PBH
Prestige Consumer Healthcare IncMbjlmjbDphtqr$3.2 Bil
GTBIF
Green Thumb Industries IncStdcjpczlVvsp$3.1 Bil

Sponsor Center